Sulfonated dextran inhibits complement activation and complement- dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection

Molecular Immunology

Volumn 33, Issue 7-8, 1996, Pages 643-648

  Thomas, Helene ^a   Maillet, Francoise ^a   Letourneur, Didier ^b   Jozefonvicz, Jacqueline ^b   Fischer, Elizabeth ^a   Kazatchkine, Michel D ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

complement; polymers; sulfated dextran; xenogeneic model

Indexed keywords

CARBOXYL GROUP; CARBOXYMETHYL BENZYLAMIDE SULFONATE DEXTRAN DERIVATIVE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEXTRAN DERIVATIVE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CHROMIUM 51 RELEASE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0030152130     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(96)00028-4     Document Type: Article

References (26)

1. Crepon B., Maillet F., Kazatchkine M. D. and Jozefonvicz J. (1987) Molecular weight dependency of the acquired anti-complementary and anticoagulant activities of specifically substituted dextrans. Biomaterials 8, 248-253.
2. Dalmasso A. P., Falk R. J. and Raij L. (1989) The pathobiology of the terminal complement complexes. Compl. Inflamm. 6, 36-48.
3. Dalmasso A. P., Vercellotti G. M., Platt J. L. and Bach F. H. (1991) Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Transplantation 52, 530-533.
4. Dalmasso A. P. and Platt J. L. (1993) Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 56, 1171-1176.
5. Frank M. M. and Fries L. F. (1991) The role of complement in inflammation and phagocytosis. Immun. Today 12, 322-326.
6. Hamilton K. K., Hattori R., Esmon C. T. and Sims P. J. (1990) Complement proteins C5b-9 induce vesiculation of endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J. biol. Chem. 265, 3809-3814.
7. Kazatchkine M. D., Fearon D. T., Metcalf D. D., Rosenberg R. D. and Austen K. F. (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J. clin. Invest. 67, 223-228.
8. Kennedy S. P., Rollins S. A., Burton W. V., Sims P. J., Bothwell A. L. M., Squinto S. P. and Zavoico G. B. (1994) Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation 57, 1494-1501.
9. Leventhal J. R., Dalmasso A. P., Cromwell J. W., Platt J. L., Manivel C. J., Morton Bolman III R. and Matas A. J. (1993) Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857.
10. Loveland B. F., Johnstone R. W., Russell S. M., Thorley B. R. and McKenzie I. F. C. (1993) CD46 (MCP) confers protection from lysis by xenogeneic antibodies. Transplant. Proc. 25, 396-397.
11. Maillet F., Frémeaux-Bacchi V., Uhring-Lambert B. and Kazatchkine M. D. (1992) Assessment of complement activation in clinical samples. Comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments. J. immunol. Meth. 156, 171-178.
12. Mauzac M., Maillet F., Josefonvicz J. and Kazatchkine M. D. (1985) Anticomplementary activity of dextran derivates. Biomaterials 6, 1961-1963.
13. Millan M. T., Ferran C., Winkler M. L., van der Werf W. J., Hancock W. W. and Bach F. H. (1994) Xenotransplantation: problems and approaches. Transplant. Proc. 26, 3593-3596.
14. Platt J. L., Vercellotti G. M., Lindman B. J., Oegema T. R., Bach F. H. and Dalmasso A. P. (1990) Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J. exp. Med. 171, 1363-1368.
15. Platt J. L., Turman M. A., Noreen H. J., Fischel R. J., Morton Bolman III R. and Bach F. H. (1990) An ELISA assay for xenoreactive natural antibodies. Transplantation 49, 1000-1001.
16. Platt J. L., Fischel R. J., Matas A. J., Reif S. A., Morton Bolman R. and Bach F. H. (1991) Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52, 214-220.
17. Platt J. L., Dalmasso A. P., Lindman B. J., Ihrcke N. S. and Bach F. H. (1991) The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immun. 21, 2887-2890.
18. Platt J. L. (1992) Mechanisms of tissue injury in hyperacute xenograft rejection. ASIAO J. 38, 8-16.
19. Pruitt S. K., Kirk A. D., Bollinger R. R., Marsh H. C. Jr., Collins B. H., Levin J. L., Mault J. R., Heinle J. S., Ibrahim S., Rudolph A. R., et al. (1994) The effect of soluble human complement receptor type 1 on hyperacute rejection porcine xenografts. Transplantation 57, 363-370.
20. Ronda N., Haury M., Nobrega A., Kaveri S. V., Coutinho A. and Kazatchkine M. D. (1994) Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int. Immun. 6, 1651-1660.
21. Saadi S. and Platt J. L. (1995) Transient perturbation of endothelial integrity induced by natural antibodies and complement. J. exp. Med. 181, 21-31.
22. Stevens R. B., Wang Y. L., Kaji H., Lloveras J., Dalmasso A. P., Bach F. H., Rubinstein P., Sutherland D. E. R. and Platt J. L. (1993) Administration of non-anticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Transplant. Proc. 25, 382.
23. Thomas H., Maillet F., Letourneur D., Jozefonvicz J. and Kazatchkine M. D. (1995) Substituted dextran derivative inhibits complement activation in vivo. Biomaterials 16, 1163-1167.
24. Vercellotti G. M., Platt J. L., Bach F. H. and Dalmasso A. P. (1991) Neutrophil adhesion to xenogeneic endothelium via iC3b. J. Immun. 146, 730-734.
25. Vogt W. (1986) Anaphylatoxins: possible roles in diseases. Complement 3, 177-188.
26. Zhao Z., Termignon J. L., Cardoso J., Chereau C., Gauteau C., Calmus Y., Houssin D. and Weil B. (1993) Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. Transplantation 57, 245-249.